Study: NCT01529645

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Acellular pertussis vaccine
Description: Acellular pertussis (aP) vaccine was administered with different antigen doses intramuscularly in the upper deltoid region of the subject's non-dominant arm.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Acellular pertussis vaccine
Description: Acellular pertussis (aP) vaccine was administered with different antigen doses intramuscularly in the upper deltoid region of the subject's non-dominant arm.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Acellular pertussis vaccine
Description: Acellular pertussis (aP) vaccine was administered with different antigen doses intramuscularly in the upper deltoid region of the subject's non-dominant arm.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Tetanus, reduced diphtheria, and acellular pertussis vaccine (adsorbed)
Description: Tetanus, reduced diphtheria, and acellular pertussis (TdaP) vaccine was administered with different antigen doses intramuscularly in the upper deltoid region of the subject's non-dominant arm.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Tetanus, reduced diphtheria, and acellular pertussis vaccine (adsorbed)
Description: Tetanus, reduced diphtheria, and acellular pertussis (TdaP) vaccine was administered with different antigen doses intramuscularly in the upper deltoid region of the subject's non-dominant arm.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Tetanus, reduced diphtheria, and acellular pertussis vaccine (adsorbed)
Description: Tetanus, reduced diphtheria, and acellular pertussis (TdaP) vaccine was administered with different antigen doses intramuscularly in the upper deltoid region of the subject's non-dominant arm.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Tetanus, reduced diphtheria, and acellular pertussis vaccine (adsorbed)
Description: Tetanus, reduced diphtheria, and acellular pertussis (TdaP) vaccine was administered with different antigen doses intramuscularly in the upper deltoid region of the subject's non-dominant arm.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Tetanus, reduced diphtheria, and acellular pertussis vaccine (adsorbed)
Description: Tetanus, reduced diphtheria, and acellular pertussis (TdaP) vaccine was administered with different antigen doses intramuscularly in the upper deltoid region of the subject's non-dominant arm.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Tetanus, reduced diphtheria, and acellular pertussis vaccine (adsorbed)
Description: Tetanus, reduced diphtheria, and acellular pertussis (TdaP) vaccine was administered with different antigen doses intramuscularly in the upper deltoid region of the subject's non-dominant arm.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Licensed TdaP booster vaccine
Description: Licenced TdaP booster vaccine was administered intramuscularly in the upper deltoid region of the subject's non-dominant arm.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Diphtheria and tetanus vaccine (adsorbed, reduced antigen content, Germany)
Description: To ensure all subjects receive a tetanus and diphtheria booster vaccination, an injection was administered on Study Day 30, one month after the administration of the investigational vaccine.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Diphtheria and tetanus vaccine (adsorbed, reduced antigen content, Germany)
Description: To ensure all subjects receive a tetanus and diphtheria booster vaccination, an injection was administered on Study Day 30, one month after the administration of the investigational vaccine.

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Diphtheria and tetanus vaccine (adsorbed, reduced antigen content, Germany)
Description: To ensure all subjects receive a tetanus and diphtheria booster vaccination, an injection was administered on Study Day 30, one month after the administration of the investigational vaccine.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Saline solution
Description: Subjects received one injection of saline solution at one month after vaccination.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Saline solution
Description: Subjects received one injection of saline solution at one month after vaccination.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Saline solution
Description: Subjects received one injection of saline solution at one month after vaccination.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Saline solution
Description: Subjects received one injection of saline solution at one month after vaccination.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Saline solution
Description: Subjects received one injection of saline solution at one month after vaccination.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Saline solution
Description: Subjects received one injection of saline solution at one month after vaccination.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Saline solution
Description: Subjects received one injection of saline solution at one month after vaccination.